Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 01, 2017 09:15 ET | Source: Forward Pharma A/S

Forward Pharma Appoints Claus Bo Svendsen as Chief Executive Officer and Plans to Reorganize to Reduce Burn Rate Following the Settlement and License Agreement with Biogen

COPENHAGEN, Denmark, March 01, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we” or the “Company”) today announced that its Board of Directors has appointed Claus Bo Svendsen, M.D.,...
February 09, 2017 08:30 ET | Source: Forward Pharma A/S

Forward Pharma Received US$ 1.25bn pursuant to Settlement and License Agreement with Biogen

COPENHAGEN, Denmark, Feb. 09, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we” or “Forward”) today announced that it has received a non-refundable cash fee of US$ 1.25 billion in...
February 01, 2017 09:15 ET | Source: Forward Pharma A/S

Forward Pharma Announces Results of Extraordinary General Meeting

COPENHAGEN, Denmark, Feb. 01, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we” or “Forward”) today announced that, at an extraordinary general meeting of its shareholders held on...
January 17, 2017 11:01 ET | Source: Forward Pharma A/S

Forward Pharma Agrees to Enter Into Settlement and License Agreement with Biogen

Biogen will pay Forward a non-refundable cash fee of $1.25 billionForward may be eligible to receive royalties of 10% of net sales of Tecfidera beginning in 2021, and of 20% of net sales beginning in...
November 29, 2016 16:15 ET | Source: Forward Pharma A/S

Forward Pharma Reports Third Quarter 2016 Financial and Operational Results

COPENHAGEN, Denmark, Nov. 29, 2016 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we” or “Forward” or the “Company”), today reported financial results for the third quarter ended September...
November 02, 2016 08:00 ET | Source: Forward Pharma A/S

Forward Pharma CFO to Participate in the Credit Suisse Annual Healthcare Conference in November

COPENHAGEN, Denmark, Nov. 02, 2016 (GLOBE NEWSWIRE) -- Forward Pharma A/S (FWP) (the “Company”), a biopharmaceutical company working to advance a proprietary formulation of DMF (dimethyl fumarate)...
September 06, 2016 08:00 ET | Source: Forward Pharma A/S

Forward Pharma CFO to Participate in Three Investor Conferences in September

COPENHAGEN, Denmark, Sept. 06, 2016 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”), a biopharmaceutical company working to advance a proprietary formulation of DMF (dimethyl...
September 01, 2016 08:00 ET | Source: Forward Pharma A/S

Forward Pharma Reports Second Quarter 2016 Financial and Operational Results

COPENHAGEN, Denmark, Sept. 01, 2016 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we” or “Forward” or the “Company”), today reported financial results for the second quarter ended June 30,...
June 06, 2016 16:15 ET | Source: Forward Pharma A/S

Forward Pharma CFO to Participate in Two Investor Conferences in June

COPENHAGEN, Denmark, June 06, 2016 (GLOBE NEWSWIRE) -- Forward Pharma A/S (Nasdaq:FWP) (the “Company”), a biopharmaceutical company working to advance a proprietary formulation of DMF (dimethyl...
June 02, 2016 16:15 ET | Source: Forward Pharma A/S

Forward Pharma Reports First Quarter 2016 Financial and Operational Results

COPENHAGEN, Denmark, June 02, 2016 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“We” or “Forward” or the “Company”), today reported financial results for the first quarter ended March 31,...